- Press releasesPress releases
- Events & ActivityEvents & Activity
- Veracyte Announces New Data Demonstrating “Real-World” Performance of Afirma GSC To Be Presented at ENDO 2018
- Veracyte Announces Fourth Quarter and Full-Year 2017 Financial Results, Provides 2018 Financial Outlook
- Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2017 Financial Results on Tuesday, February 27, 2018
- Veracyte to Present at LEERINK Partners 7th Annual Global Healthcare Conference
- Veracyte Announces 100,000th Afirma Test Performed to Reduce Unnecessary Surgeries in Thyroid Cancer Diagnosis
- Veracyte’s Chief Science and Medical Officer to Present at The Precision Medicine World Conference
- Veracyte Announces Publication of Results from Patient Survey Quantifying the Challenges in Diagnosing Interstitial Lung Disease
- Veracyte Announces Strategic Realignment and New Appointments to Advance Commercial Growth
Veracyte Inc (VCYT:NMQ) closed at 6.19, 18.36% above the 52 week low of 5.23 set on Feb 15, 2018.
5.23Feb 15 20189.80Oct 20 2017
Markit short selling activity
|Market cap||212.26m USD|
|EPS (TTM)||-0.9138 |
Data delayed at least 15 minutes, as of Mar 16 2018 20:00 BST.